نتایج جستجو برای: bacterial reverse mutation assay

تعداد نتایج: 777536  

Introduction: Mutations in the BRCA1 gene are major risk factors for breast and ovarian cancers. However, the relationship between some BRCA1 mutations and cancer risk remains largely unknown. Cancer risk predictions could be improved by evaluation of the impairment degree in the BRCA1 functions due to a specific mutation. This study aimed to assess the functional effect of a novel variant (Glu...

2012

(7) Claxton, L., Houk, V.S., Monteith, L.G., Myers, L.E., Hughes, T.J., ‘‘Assessing the use of known mutagens to calibrate the Salmonella typhimurium mutagenicity assay: I. Without exogenous activation.’’ Mutation Research 253:137–147 (1991). (8) Claxton, L., Houk, V.S., Warner, J.R., Myers, L.E., Hughes, T.J., ‘‘Assessing the use of known mutagens to calibrate the Salmonella typhimurium mutage...

2014
Rui-Rui Wang Qing-Hua Yang Rong-Hua Luo You-Mei Peng Shao-Xing Dai Xing-Jie Zhang Huan Chen Xue-Qing Cui Ya-Juan Liu Jing-Fei Huang Jun-Biao Chang Yong-Tang Zheng

Azvudine is a novel nucleoside reverse transcriptase inhibitor with antiviral activity on human immunodeficiency virus, hepatitis B virus and hepatitis C virus. Here we reported the in vitro activity of azvudine against HIV-1 and HIV-2 when used alone or in combination with other antiretroviral drugs and its drug resistance features. Azvudine exerted highly potent inhibition on HIV-1 (EC(50)s r...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2001
G Tachedjian M Orlova S G Sarafianos E Arnold S P Goff

Nonnucleoside reverse transcriptase inhibitors (NNRTIs) are allosteric inhibitors of the HIV type 1 (HIV-1) reverse transcriptase (RT). Yeast grown in the presence of many of these drugs exhibited dramatically increased association of the p66 and p51 subunits of the HIV-1 RT as reported by a yeast two-hybrid assay. The enhancement required drug binding by RT; introduction of a drug-resistance m...

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007
Jeffrey N Weitzel Veronica I Lagos Josef S Herzog Thaddeus Judkins Brant Hendrickson Jason S Ho Charité N Ricker Katrina J Lowstuter Kathleen R Blazer Gail Tomlinson Tom Scholl

BACKGROUND Large rearrangements account for 8% to 15% of deleterious BRCA mutations, although none have been characterized previously in individuals of Mexican ancestry. METHODS DNA from 106 Hispanic patients without an identifiable BRCA mutation by exonic sequence analysis was subjected to multiplexed quantitative differential PCR. One case of Native American and African American ancestry wa...

Journal: :British Journal of Cancer 1978

2012
Jun Nakamura Husamettin Gul Xu Tian Scott J. Bultman James A. Swenberg

While isogenic DT40 cell lines deficient in DNA repair pathways are a great tool to understand the DNA damage response to genotoxic agents by a comparison of cell toxicity in mutants and parental DT40 cells, no convenient mutation assay for mutagens currently exists for this reverse-genetic system. Here we establish a proaerolysin (PA) selection-based mutation assay in DT40 cells to identify gl...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید